Markets:

Overview

News

Currencies

International

Treasuries

Heron Therapeutics, Inc. - Common Stock (NQ:HRTX)

1.285 -0.015 (-1.15%)

Streaming Delayed Price Updated: 12:40 PM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Heron Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV)

December 04, 2025

From Heron Therapeutics, Inc.

Via GlobeNewswire

Heron Therapeutics Inc (NASDAQ:HRTX) Reports Mixed Q3 2025 Results, Misses Revenue and Earnings Estimates ↗

November 04, 2025

Heron Therapeutics reported mixed Q3 2025 results, missing revenue and earnings estimates. Despite strong growth from its Acute Care products, the miss led to a negative market reaction.

Via Chartmill

Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress

November 04, 2025

From Heron Therapeutics, Inc.

Via GlobeNewswire

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

Earnings Scheduled For February 27, 2025 ↗

February 27, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Heron Therapeutics Inc. (NASDAQ: HRTX) Near the Top of Equities by Percentage Gain on 4/23

April 23, 2024

Via Investor Brand Network

Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors

October 29, 2025

From Heron Therapeutics, Inc.

Via GlobeNewswire

Heron Therapeutics to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

October 21, 2025

From Heron Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 08, 2025

Via Benzinga

Heron Therapeutics: Q4 Earnings Insights ↗

March 12, 2024

Via Benzinga

Preview: Heron Therapeutics's Earnings ↗

March 11, 2024

Via Benzinga

These stocks are moving in today's session ↗

August 08, 2025

Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Traders are paying attention to the gapping stocks in Friday's session. ↗

August 08, 2025

Today's session on Friday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

Heron (HRTX) Q2 Acute Care Jumps 56% ↗

August 08, 2025

Via The Motley Fool

Topics Economy Intellectual Property

This Ryder System Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗

June 09, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 04, 2024

Via Benzinga

Why Marvell Technology Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

December 04, 2024

Via Benzinga

Starbucks To $77? Here Are 10 Top Analyst Forecasts For Wednesday ↗

November 13, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 12, 2024

Via Benzinga

HRTX Stock Earnings: Heron Therapeutics Misses EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

HRTX stock results show that Heron Therapeutics missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

Top 3 Health Care Stocks That May Crash In May ↗

May 24, 2024

Via Benzinga

HRTX Stock Earnings: Heron Therapeutics Beats EPS, Beats Revenue for Q1 2024 ↗

May 07, 2024

HRTX stock results show that Heron Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

HealthStream Reports Upbeat Results, Joins Spotify, Ryder System And Other Big Stocks Moving Higher On Tuesday ↗

April 23, 2024

Via Benzinga

Why Is Postoperative Pain Focused Heron Therapeutics Stock Trading Higher On Wednesday? ↗

March 13, 2024

Heron Therapeutics' Q4 2023 results: Beat EPS consensus at $(0.07), $34.23 million sales, up 14% Y/Y. Strong momentum in acute and oncology care franchises. Fiscal year 2024 guidance: $138 million-$158...

Via Benzinga

Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

April 23, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 13, 2024

Via Benzinga

Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 13, 2024

Shares of Clover Health Investments, Corp. (NASDAQ: CLOV) rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24...

Via Benzinga

Earnings Scheduled For March 12, 2024 ↗

March 12, 2024

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.